Profilo
Christopher Williams is currently the Chief Communications Officer at Compass Pathways Plc.
Previously, he worked as the Vice President & Head-Corporate Communications at Sanofi SA. He also served as the Head-Media Relations at Juno Therapeutics, Inc. from 2016 to 2018.
Posizioni attive di Christopher Williams
| Società | Posizione | Inizio |
|---|---|---|
| COMPASS PATHWAYS PLC | Public Communications Contact | - |
Precedenti posizioni note di Christopher Williams
| Società | Posizione | Fine |
|---|---|---|
| JUNO THERAPEUTICS INC | Public Communications Contact | 01/02/2018 |
| Sanofi SA | Public Communications Contact | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| COMPASS PATHWAYS PLC | Health Technology |
| Aziende private | 2 |
|---|---|
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
| Sanofi SA | Health Technology |
- Borsa valori
- Insiders
- Christopher Williams
